HealthInvest Partners Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
VAR
Varian Medical Systems, Inc.
VAR
|
+$15.8M |
| 2 |
Supernus Pharmaceuticals
SUPN
|
+$14.6M |
| 3 |
LPNT
LifePoint Health, Inc.
LPNT
|
+$8.76M |
| 4 |
Charles River Laboratories
CRL
|
+$7.18M |
| 5 |
OraSure Technologies
OSUR
|
+$1.44M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AET
Aetna Inc
AET
|
+$27.5M |
| 2 |
Elevance Health
ELV
|
+$9.99M |
| 3 |
Pfizer
PFE
|
+$2.87M |
| 4 |
SURG
SYNERGETICS USA, INC.
SURG
|
+$1.56M |
| 5 |
Artivion
AORT
|
+$1.01M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 91.52% |
| 2 | Financials | 7.54% |
| 3 | Miscellaneous | 0.93% |
Similar funds
HealthInvest Partners's Q3 2015 Portfolio in Review
As of Q3 2015, HealthInvest Partners held 18 positions worth $169M, down 14% from $196M the previous quarter. Its ten largest holdings account for 97% of the portfolio.
HealthInvest Partners deployed $9.52M of net new capital in Q3 2015, opening 4 new positions and adding to 6 existing holdings. Its largest new stake was Varian Medical Systems, Inc.: 216,672 shares worth $14M.
By sector, the portfolio is most concentrated in Healthcare at 92% of assets, up from 76% a quarter earlier, followed by Financials and Miscellaneous.
On the sell side, the largest reduction was Elevance Health, an estimated $9.99M trimmed.
- HealthInvest Partners's largest Q3 2015 buy was Varian Medical Systems, Inc.: 216,672 shares worth $14M.
- HealthInvest Partners added most to LifePoint Health, Inc. in Q3 2015, an estimated $8.76M increase.
- HealthInvest Partners's biggest Q3 2015 reduction was Elevance Health, cutting an estimated $9.99M.
- HealthInvest Partners fully exited Aetna Inc in Q3 2015, selling an estimated $27.5M.
- HealthInvest Partners's ten largest holdings make up 97% of its $169M portfolio in Q3 2015.
- HealthInvest Partners opened 4 new positions and closed 4 in Q3 2015.
- HealthInvest Partners's portfolio value fell 14% quarter-over-quarter to $169M.
Based on HealthInvest Partners's 13F filing for Q3 2015, filed 13 Oct 2015.